MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/jcmm.17543

Медицинская библиотека · Journal of cellular and molecular medicine · 2022

A retrospective analysis of EBV-DNA status with the prognosis of lymphoma.

Qiu Lihua, Si Junqi, Kang Junnan, Chen Zehui, Nuermaimaiti Rexidan, Qian Zhengzi, Li Lanfang, Zhou Shiyong, You Mingjian James, Zhang Huilai, Tian Chen

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

Epstein-Barr virus (EBV) infection is proved to be associated with clinicopathology of lymphoma. However, little is known about the relationship between EBV-DNA status after treatment and prognosis. In this study, real-time polymerase chain reaction (PCR) was used for quantitative detection of EBV-DNA load in peripheral blood of all 26,527 patients with lymphoma, and the clinical characteristics and prognosis of 202 patients were retrospectively analysed, including 100 patients with positive EBV-DNA and 102 randomly selected patients with negative EBV-DNA. We found that the average rate of EBV-DNA positivity in lymphomas was 0.376%, and EBV-DNA-positive patients presented higher risk with elevated lactate dehydrogenase (LDH) and β2-MG level, B symptoms, secondary hemophagocytic syndrome and lower objective response rate compared to EBV-DNA-negative patients. Multivariate analysis revealed EBV-DNA-positive patients had inferior progression-free survival (PFS) and overall survival (OS) and EBV-DNA level before treatment was related to PFS but not OS of T/NK cell lymphoma. In T/NK cell lymphoma, EBV-DNA converting negative after treatment was correlated with better PFS but not OS, and second-line therapy could induce more EBV-DNA-negative conversion compared to CHOP-based therapy. In all, EBV-DNA positivity before treatment can be a biomarker representing the tumour burden and an independent prognostic factor. EBV-DNA-negative conversion after treatment is a good prognostic factor for T/NK cell lymphomas.

Для цитирования: Qiu Lihua, Si Junqi, Kang Junnan, Chen Zehui, Nuermaimaiti Rexidan, Qian Zhengzi, Li Lanfang, Zhou Shiyong, You Mingjian James, Zhang Huilai, Tian Chen. A retrospective analysis of EBV-DNA status with the prognosis of lymphoma.. Journal of cellular and molecular medicine. 2022. DOI: 10.1111/jcmm.17543.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.